ReviewWorld journal of gastroenterology2022

Current status of novel biologics and small molecule drugs in the individualized treatment of inflammatory bowel disease.

Yi-Han Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.